Stoke Therapeutics, Inc. Common Stock (STOK) is a publicly traded Healthcare sector company. As of May 20, 2026, STOK trades at $30.76 with a market cap of $1.81B and a P/E ratio of -10.54. STOK moved +1.13% today. Year to date, STOK is -6.93%; over the trailing twelve months it is +201.44%. Its 52-week range spans $5.35 to $40.22. Analyst consensus is strong buy with an average price target of $46.71. Rallies surfaces STOK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Stoke Therapeutics, Inc. Common Stock (STOK) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. STOK moved +1.13% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $30.76 |
| Market Cap | $1.81B |
| P/E Ratio | -10.54 |
| EPS | $-2.84 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.22 |
| 52-Week Low | $5.35 |
| Volume | 506.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $32.08M |
| Net Income | $-169.77M |
| Gross Margin | 0.00% |
8 analysts cover STOK: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $46.71.